Jefferies Reiterates Buy Rating on WAVE Life Sciences (WVE)

December 12, 2025 3:38 AM EST Send to a Friend
Jefferies analyst Roger Song reiterated a Buy rating and $26.00 price target on WAVE Life Sciences (NASDAQ: WVE).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login